Molecular characterization of acute myeloblastic leukemia according to the new WHO classification: A different distribution in Central-West Spain

Haematologica

Volumn 86, Issue 2, 2001, Pages 162-166

  Chillon M C ^a   Garcia Sanz R ^a   Balanzategui, A ^a   Ramos, F ^a   Fernandez Calvo J ^a   Rodriguez M J ^a   Rodriguez Salazar M I ^a   Corrales, A ^a   Calmuntia, M J ^a   Orfao, A ^a   Gonzalez M ^a   San Miguel, J F ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Acute myeloblastic leukemia; AML1 ETO; CBF MYH11; MLL gene; PML RAR

Indexed keywords

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CHROMOSOME TRANSLOCATION; DISEASE CLASSIFICATION; FEMALE; GENE MAPPING; GENETIC EPIDEMIOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; SPAIN; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHROMOSOME ABERRATIONS; FEMALE; GENE FREQUENCY; HUMANS; INCIDENCE; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; SPAIN; WORLD HEALTH ORGANIZATION;

EID: 0035103622     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Recurring chromosome abnormalities in leukemia and lymphoma
2. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the clinical advisory committee meeting - Airlie House, Virginia, November 1997
3. All-trans-retinoic acid in acute promyelocytic leukemia
4. Acute promyelocytic leukemia: A curable disease
5. A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARα-positive acute promyelocytic leukemia
6. Clinical significance of cytogenetics in acute myeloid leukemia
7. The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1612 patients entered into the MRC AML 10 Trial
8. Prognostic significance of karyotype in de novo adult acute myeloid leukemia
9. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease
10. Frequency of CBFβ/MYH11 fusion transcripts in patients entered into the U.K. MRC AML trials
11. Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trials
12. Geographic heterogeneity of neoplasia-associated chromosome aberrations
13. High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia
14. Acute myeloid leukemia: Presentation of the disease and response to treatment in Northeast Brazil
15. High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia
16. Promyelocytic leukemia in Mexican Mestizos
17. About the increased frequency of acute promyelocytic leukemia among Latinos: The experience from a center in Spain
18. Chromosome studies on 30 Chinese patients with acute nonlymphocytic leukemia in Taiwan
19. Geographic heterogeneity of cellular characteristics of acute myeloid leukemia: A comparative study of Australian and Japanese adult cases
20. Quantitative acute leukemia cytogenetics
21. Karyotype analysis in acute nonlymphocytic leukemia (ANLL): Comparison with ethnic group, age, morphology and survival
22. Low frequency of the TEL/AML1 fusion gene in acute lymphoblastic leukaemia in Spain
23. Proposed revised criteria for the classification of acute myeloid leukemia
24. Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients
25. The flow cytomettic pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML/RARα gene rearrangements
26. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
27. Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, MLL p53 AND p16 genes in B-cell non-Hodgkin's lymphomas. Value of molecular analysis for a better assignment of the histologic subtype
28. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 1 1q23 chromosomal translocations
29. Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): Two multicenter studies of the German AML Cooperative Group
30. Prognostic impact of cytogenetic abnormalities in patients with de novo acute non lymphocytic leukemia
31. The clinical significance of karyotype in acute myelogenous leukemia
32. Cytogenetics and their prognostic value in de novo acute myeloid leukaemia: A report on 283 cases
33. Intensive post remission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B
34. Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia
35. Acute promyelocytic leukemia in chirdren: Experience of the Italian Pediatric Hematology and Oncology Group (AIEOP)
36. Associations between morphology, karyotype, and clinical features in myeloid leukemias
37. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene AML1
38. Translocation breakpoints are clustered on both chromosome 8 and chromosome 21 in the t(8;21) of acute myeloid leukemia
39. Geographic heterogeneity of chromosome aberrations in hematologic disorders
40. Molecular detection of t(8;21)/AML-ETO in M1/M2: Correlation with cytogenetics, morphology and immunophenotype
41. Diagnosis, front line treatment and molecular monitoring of acute promyelocytic leukaemia